Therapeutic bacteriophages
AssigneeUniversity of Leicester
InventorsMartha Clokie, Anisha Thanki
Life of this patent
Estimating the term…
Abstract
There is provided a bacteriophage of the Myoviridae family, comprising a genome of circularly permuted double-stranded DNA at a length of 200 kbp or more; characterised in that the phage has any one or more of the following features: a) does not have a holin gene; and/or b) binds to the Salmonella lipopolysaccharide; and/or c) has only one tail fibre protein; and d) has a sequence with at least 95% sequence identity to SEQ ID NO. 7 and/or a sequence with at least 80% sequence identity to SEQ ID NO. 8. Suitably, the bacteriophage may be used to treat salmonella, in particular in the treatment of salmonella in pigs and fowl.
Claims15
A panel of bacteriophages, the panel comprising:
- (a) a bacteriophage with deposit number NCTC 18080703;
- and
- (b) one or more bacteriophages selected from the group consisting of bacteriophages with deposit numbers NCTC 18080701, NCTC 18080702, NCTC 18080704, NCTC 18080705, and NCTC 18080706;
- wherein the bacteriophages of the panel are spray-dried.
Dependencies are inferred from the claim text.